Valneva’s not too late in the vaccine race: analysts To view this email as a web page,
click here | | Webinar: Accelerating NASH Clinical Trials Tuesday, June 15 | 10am ET / 7am PT Join industry leaders for a webinar dedicated to overcoming key challenges presented in NASH drug development. We’ll explore key considerations for liver biopsy collection and interpretation, emerging non-invasive biomarkers, and the connection between clinical practice and drug development. Register now. |
AstraZeneca in talks to produce COVID-19 vaccine for feds at Catalent site in Maryland: report Valneva's not too late in COVID-19 as analysts eye $1.1B in 2022 vaccine sales UPDATED Coronavirus tracker: U.S. to donate 25M vaccines to other countries Solera Health partners with Headspace to expand mental health tools for payers, employers COVID-19 tracker: Roche, Regeneron strike EU deal for antibody cocktail New House and Senate bill aims to tackle primary care doctor shortage Featured Story | By Fraiser Kansteiner With production nixed at a Baltimore plant—and its shot’s role in the U.S. vaccination scheme uncertain—AstraZeneca may turn to one of its established pandemic manufacturing partners to crank out doses for the feds. read more |
| |
|---|
|
Top Stories By Noah Higgins-Dunn Valneva’s COVID-19 vaccine could bring in roughly $1.1 billion in 2022 revenues through supply deals and more than $500 million in 2023, Jefferies analysts predicted. The vaccine, dubbed VLA2001, is currently in late-stage trials with a readout expected in the third quarter. read more By Healthcare Staff Follow along with the latest COVID-19 news straight from the Fierce Healthcare team. read more By Heather Landi Solera Health is teaming up with Headspace to offer the startup's meditation, mindfulness and mental training app directly to payer and employer member populations. read more By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner The Biden administration said it would give the vaccine sharing facility COVAX 75%, or roughly 19 million doses, of the first 25 million doses it will donate to other countries. The European Union secured 55,000 doses of the Roche-Regeneron antibody cocktail for non-hospitalized patients. And more headlines. read more By Robert King Congress is pursuing legislation that would boost funding for graduate medical education by $500 million in an effort to head off a shortage of primary care physicians. read more |
|
